HCA Healthcare, Inc.
- Jurisdiction
United States - LEI
529900PH4ZGUH2MNEU89 - ISIN
US40412C1018 (HCA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€300.80 19.1% overvalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. Read full profile
Stock price
Fundamentals
- Net revenue
€62.01B - Gross margin
63.1% - EBIT
€6.92B - EBIT margin
11.2% - Net income
€3.69B - Net margin
5.9%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Dividends
- Last dividend amount
-
$0.72 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
15.8%
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Val Hoyle | September 12, 2025 | $1.00K–$15.00K |
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
| Val Hoyle | September 12, 2025 | $1.00K–$15.00K |
| Jared Moskowitz | June 27, 2025 | $1.00K–$15.00K |
| Julie Johnson | May 14, 2025 | $1.00K–$15.00K |
Earnings Calls
Latest earnings call: July 25, 2025
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Andreas Halvorsen |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Sell |